← Leaderboards
Timothy Lu
Massachusetts Institute Of Technology
$4,948,805
Attributed
$6,448,489
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2011–21$2.5M$1.9M$1.3M$625K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$6,448,489 · 5
By mechanism
DP2$2,407,500 · 1
U01$1,844,340 · 1
R33$1,253,034 · 1
R21$943,615 · 2
Top collaborators
- Bonnie Berger2 shared
- Christina S Faherty2 shared
- Omer Yilmaz2 shared
Most similar at Massachusetts Institute Of Technology
Same institution · by research overlap
- David B Schauer$5,515,535
- Ronald T Raines$23,937,707
- Michael Laub$6,675,337
- Alan D Grossman$31,123,842
- Kevin M Esvelt$947,413
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseInnovationTechnologyResistanceIn VitroEngineeringBacteriaCombatProtocols DocumentationPublic HealthMutagenesisLibrariesPathogenAntibiotic ResistanceInfectionAntibioticsBacteriophagesEscherichia ColiIn VivoIn Vivo ModelSpecificityMissionPublic Health RelevancePreclinical Development
Grant awards (10)
Developing high-throughput genetic perturbation strategies for single cells in cancer organoids$922,170
U01 · FY2021 · CA · contact PI
Development of Novel Bacteriophages Targeting Enteric Bacterial Pathogens$249,312
R21 · FY2021 · AI
Developing high-throughput genetic perturbation strategies for single cells in cancer organoids$922,170
U01 · FY2020 · CA · contact PI
Engineering âPhagebodyâ Antimicrobials for Carbapenem-Resistant Enterobacteriaceae$402,463
R33 · FY2020 · AI · contact PI
Development of Novel Bacteriophages Targeting Enteric Bacterial Pathogens$290,937
R21 · FY2020 · AI
Engineering âPhagebodyâ Antimicrobials for Carbapenem-Resistant Enterobacteriaceae$417,876
R33 · FY2019 · AI · contact PI
Engineering âPhagebodyâ Antimicrobials for Carbapenem-Resistant Enterobacteriaceae$432,695
R33 · FY2018 · AI · contact PI
Engineering âPhagebodyâ Antimicrobials for Carbapenem-Resistant Enterobacteriaceae$213,383
R21 · FY2017 · AI · contact PI
Engineering âPhagebodyâ Antimicrobials for Carbapenem-Resistant Enterobacteriaceae$189,983
R21 · FY2016 · AI · contact PI
High-Throughput Nanoscale Approaches to Studying and Inhibiting Amyloid Toxicity$2,407,500
DP2 · FY2011 · OD · contact PI